Rachel McMinn

Rachel McMinn

Vorstandsvorsitzender bei Neurogene, Inc.

51 Jahre
Finance
Consumer Services
Health Technology

Profil

Rachel L.
McMinn
is the founder and currently holds the position of Chief Executive Officer at Neurogene, Inc., a company founded in 2018.
She is also the Chairman & Chief Executive Officer at Neurogene, Inc., a position she has held since 2023.
Additionally, Dr. McMinn is currently a Director at EveryONE Medicines, Inc., starting in 2021.
In her former positions, Dr. McMinn was a Director at Cowen & Co. LLC from 2007 to 2009.
She also served as a Senior Analyst at Piper Sandler & Co. (Broker).
From 2014 to 2017, she held the role of Chief Business & Strategy Officer at Intercept Pharmaceuticals, Inc. Dr. McMinn was a Principal at Banc of America Securities LLC in 2009.
She also worked as an Analyst at Piper Sandler & Co. and Merrill Lynch, Pierce, Fenner & Smith, Inc.Dr. McMinn's education includes a doctorate from The Scripps Research Institute and an undergraduate degree from Cornell University.

Aktive Positionen von Rachel McMinn

UnternehmenPositionBeginn
Vorstandsvorsitzender 01.01.2018
Direktor/Vorstandsmitglied 01.01.2021
Alle aktiven Positionen von Rachel McMinn

Ehemalige bekannte Positionen von Rachel McMinn

UnternehmenPositionEnde
INTERCEPT PHARMACEUTICALS, INC. Corporate Officer/Principal 01.12.2017
Analyst-Equity 30.04.2009
Analyst-Equity 31.03.2009
Analyst-Equity 31.12.2006
Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Rachel McMinn im Detail an

Ausbildung von Rachel McMinn

Cornell University Undergraduate Degree
The Scripps Research Institute Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Rachel McMinn im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

10

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen1
INTERCEPT PHARMACEUTICALS, INC.

Health Technology

Private Unternehmen7

Finance

Finance

Finance

Finance

Finance

Health Technology

Commercial Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Rachel McMinn